H.R. 6347 · 114th Congress

To extend for one year the program for priority review to encourage treatments for rare pediatric diseases.

Stage
In committee
Sponsor
Alan Grayson
Introduced
2016-11-17
Latest action
2016-11-17 · Introduced in House

Action history

  1. 2016-11-17Introduced in House
  2. 2016-11-17Referred to the House Committee on Energy and Commerce.